Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ladan Fazli

Showing results (261-270 of 270) with videos related to

Pageof 27
Sort By:
You have reached the last page of results.This site can display upto 270 results.
European Urology|April 15, 2017
An Oncofetal Glycosaminoglycan Modification Provides Therapeutic Access to Cisplatin-resistant Bladder CancerRoland Seiler, Htoo Zarni Oo, Davide Tortora, et al.
The Journal of Pathology|February 2, 2012
Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancerChunxiao Wu, Alexander W Wyatt, Anna V Lapuk, et al.
Medrxiv : the Preprint Server for Health Sciences|May 9, 2025
Identifying Rare Germline Variants Associated with Metastatic Prostate Cancer Through an Extreme Phenotype StudyYen-Yi Lin, Hamideh Sharifi Noghabi, Stanislav Volik, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 21, 2023
Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective StudyPalak Patel, Stephanie Harmon, Rachael Iseman, et al.
The Journal of Pathology|May 4, 2012
From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancerAnna V Lapuk, Chunxiao Wu, Alexander W Wyatt, et al.
Cancer Cell|October 14, 2015
Targeting Human Cancer by a Glycosaminoglycan Binding Malaria ProteinAli Salanti, Thomas M Clausen, Mette Ø Agerbæk, et al.
Nature Communications|July 26, 2017
Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancerManav Korpal, Xiaoling Puyang, Zhenhua Jeremy Wu, et al.
Nature Communications|June 6, 2019
Author Correction: Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancerManav Korpal, Xiaoling Puyang, Zhenhua Jeremy Wu, et al.
Nature Communications|January 19, 2019
ONECUT2 is a driver of neuroendocrine prostate cancerHaiyang Guo, Xinpei Ci, Musaddeque Ahmed, et al.
EMBO Molecular Medicine|January 11, 2022
THEM6-mediated reprogramming of lipid metabolism supports treatment resistance in prostate cancerArnaud Blomme, Coralie Peter, Ernest Mui, et al.
Pageof 27

Showing results (261-270 of 270) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 270 results.
European Urology|April 15, 2017
An Oncofetal Glycosaminoglycan Modification Provides Therapeutic Access to Cisplatin-resistant Bladder CancerRoland Seiler, Htoo Zarni Oo, Davide Tortora, et al.
The Journal of Pathology|February 2, 2012
Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancerChunxiao Wu, Alexander W Wyatt, Anna V Lapuk, et al.
Medrxiv : the Preprint Server for Health Sciences|May 9, 2025
Identifying Rare Germline Variants Associated with Metastatic Prostate Cancer Through an Extreme Phenotype StudyYen-Yi Lin, Hamideh Sharifi Noghabi, Stanislav Volik, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 21, 2023
Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective StudyPalak Patel, Stephanie Harmon, Rachael Iseman, et al.
The Journal of Pathology|May 4, 2012
From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancerAnna V Lapuk, Chunxiao Wu, Alexander W Wyatt, et al.
Cancer Cell|October 14, 2015
Targeting Human Cancer by a Glycosaminoglycan Binding Malaria ProteinAli Salanti, Thomas M Clausen, Mette Ø Agerbæk, et al.
Nature Communications|July 26, 2017
Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancerManav Korpal, Xiaoling Puyang, Zhenhua Jeremy Wu, et al.
Nature Communications|June 6, 2019
Author Correction: Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancerManav Korpal, Xiaoling Puyang, Zhenhua Jeremy Wu, et al.
Nature Communications|January 19, 2019
ONECUT2 is a driver of neuroendocrine prostate cancerHaiyang Guo, Xinpei Ci, Musaddeque Ahmed, et al.
EMBO Molecular Medicine|January 11, 2022
THEM6-mediated reprogramming of lipid metabolism supports treatment resistance in prostate cancerArnaud Blomme, Coralie Peter, Ernest Mui, et al.
Pageof 27